Our Speakers

KA
Kerin Adelson, MD, MS
Chief Quality and Value Officer
MD Anderson Cancer Center

JB
Jonnetta Blakely, MD, MS, MMHC
Executive VP of Quality and Clinc Operations
Tennessee Oncology

CC
Casey Chiasson
Executive Director
Wilamette Valley Cancer Institute

SF
Scott Freeswick, MS, PharmD
Chief Pharmacy Officer
Memorial Sloan Kettering
Sophia Humphreys, PharmD, MHA, BCBBS
Director, System Pharmacy Formulary Management & Clinical Programs
Sutter Health
David Jackman, MD
Medical Director, Clinical Pathways and New Business Initiatives
Dana-Farber Cancer Institute

BJ
Ben Jones
Vice President, Government Relations and Public Policy
US Oncology Network

EL
Edward Licitra
CEO
Astera

AL
Aaron Lyss
Senior Director Payment and Policy Innovation
OneOncology
Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA
Clinical Pharmacy Manager, Division of Hematologic Malignances and Cellular Therapeutics
University of Kansas Cancer Center

BM
Barbara McAneny, MD
CEO
New Mexico Oncology Hematology Consultants

KP
Kathryn Paliotta, RN
VP Patient Communication
NY Cancer and Blood Specialists

SP
Sandy Parsad, PharmD, MBA, BCOP
Director of Pharmacy
University of Chicago
Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC
Vice President of Clinical Innovation
American Oncology Network

TS
Tom Snow, MBA
General Manager, US Oncology
Sanofi

TS
Tracy Spinks
Director Value-based Care
Optum

VS
Vivek Subbiah, MD
Chief, Early-Phase Drug Development
Sarah Cancer Research Institute

ET
Erin Trish, PhD
Co-director at Leaonard D. Schaeffer Center for Health Policy and Economics
University of Southern California

JV
John Villano, MD, PhD
Director, Clinical Neuro-Oncology Research Program
University of Kentucky

DV
Dan Virnich, MD, MBA, FACHE
CEO
The Oncology Institute

BW
Bruce Wilson
VP, US Oncology Care and Access
AstraZeneca